{"disease":{"id":"the-patients-with-crlm-who-benefit-more-from-bevacizumab","name":"the patients with crlm who benefit more from bevacizumab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06023173","title":"Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Fudan University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}